A randomised open-label controlled trial of a 4-month gatifloxacin-containing regimen versus standard regimen for the treatment of adult patients with pulmonary tuberculosis

Next Previous
Trial Profile

A randomised open-label controlled trial of a 4-month gatifloxacin-containing regimen versus standard regimen for the treatment of adult patients with pulmonary tuberculosis

Completed
Phase of Trial: Phase III

Latest Information Update: 27 Feb 2017

At a glance

  • Drugs Gatifloxacin (Primary) ; Isoniazid/rifampicin; Rifampicin/isoniazid/pyrazinamide; Rifampicin/isoniazid/pyrazinamide/ethambutol
  • Indications Pulmonary tuberculosis
  • Focus Registrational; Therapeutic Use
  • Acronyms OFLOTUB

    • Most Recent Events

    • 19 Nov 2005 New trial record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top